347 related articles for article (PubMed ID: 9545226)
41. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.
Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY
Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073
[TBL] [Abstract][Full Text] [Related]
42. Proteases involved in MHC class II antigen presentation.
Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
[TBL] [Abstract][Full Text] [Related]
43. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.
Markowitz JS; Auchincloss H; Grusby MJ; Glimcher LH
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2779-83. PubMed ID: 8464889
[TBL] [Abstract][Full Text] [Related]
44. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens.
Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Kominami E; Katunuma N; Asao T; Himeno K
Biochem Biophys Res Commun; 2001 May; 283(2):499-506. PubMed ID: 11327729
[TBL] [Abstract][Full Text] [Related]
45. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
46. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
47. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
Nasreen M; Ueno T; Saito F; Takahama Y
J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
[TBL] [Abstract][Full Text] [Related]
48. Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines.
Oukka M; Andre P; Turmel P; Besnard N; Angevin V; Karlsson L; Trans PL; Charron D; Bihain B; Kosmatopoulos K; Lotteau V
Eur J Immunol; 1997 Apr; 27(4):855-9. PubMed ID: 9130635
[TBL] [Abstract][Full Text] [Related]
49. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
Farr A; DeRoos PC; Eastman S; Rudensky AY
Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.
Zavasnik-Bergant V; Schweiger A; Bevec T; Golouh R; Turk V; Kos J
Immunology; 2004 Jul; 112(3):378-85. PubMed ID: 15196205
[TBL] [Abstract][Full Text] [Related]
51. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice.
Zhang T; Maekawa Y; Hanba J; Dainichi T; Nashed BF; Hisaeda H; Sakai T; Asao T; Himeno K; Good RA; Katunuma N
Immunology; 2000 May; 100(1):13-20. PubMed ID: 10809954
[TBL] [Abstract][Full Text] [Related]
52. Invariant chain controls the activity of extracellular cathepsin L.
Fiebiger E; Maehr R; Villadangos J; Weber E; Erickson A; Bikoff E; Ploegh HL; Lennon-Duménil AM
J Exp Med; 2002 Nov; 196(9):1263-9. PubMed ID: 12417635
[TBL] [Abstract][Full Text] [Related]
53. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.
Nepal RM; Vesosky B; Turner J; Bryant P
J Leukoc Biol; 2008 Oct; 84(4):1011-8. PubMed ID: 18591414
[TBL] [Abstract][Full Text] [Related]
54. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
55. Tissue-Specific Factors Differentially Regulate the Expression of Antigen-Processing Enzymes During Dendritic Cell Ontogeny.
Mahiddine K; Hassel C; Murat C; Girard M; Guerder S
Front Immunol; 2020; 11():453. PubMed ID: 32296417
[TBL] [Abstract][Full Text] [Related]
56. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
Allan ER; Tailor P; Balce DR; Pirzadeh P; McKenna NT; Renaux B; Warren AL; Jirik FR; Yates RM
J Immunol; 2014 Jun; 192(11):4989-5001. PubMed ID: 24778444
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.
Zal T; Volkmann A; Stockinger B
J Exp Med; 1994 Dec; 180(6):2089-99. PubMed ID: 7964486
[TBL] [Abstract][Full Text] [Related]
58. Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells.
Melms A; Luther C; Stoeckle C; Pöschel S; Schroth P; Varga M; Wienhold W; Tolosa E
Acta Neurol Scand Suppl; 2006; 183():12-3. PubMed ID: 16637920
[TBL] [Abstract][Full Text] [Related]
59. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
60. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
